| Pharmaceutical Information |
| Drug Name |
Ropivacaine |
| Drug ID |
BADD_D02416 |
| Description |
Ropivacaine is an aminoamide local anaesthetic drug commonly marketed by AstraZeneca under the trade name Naropin. It is present as a racemic mixture of the enantiomers containing equal proportions of the “S” and “R” forms. The marketed form contains the single S-enantiomer as the active ingredient. |
| Indications and Usage |
Used in obstetric anesthesia and regional anesthesia for surgery. |
| Marketing Status |
Not Available |
| ATC Code |
N01BB09 |
| DrugBank ID |
DB00296
|
| KEGG ID |
D08490
|
| MeSH ID |
D000077212
|
| PubChem ID |
175805
|
| TTD Drug ID |
D09RHQ
|
| NDC Product Code |
76339-126; 29902-0022 |
| Synonyms |
Ropivacaine | 1-Propyl-2',6'-pipecoloxylidide | 1 Propyl 2',6' pipecoloxylidide | Naropin | Ropivacaine Monohydrochloride | Ropivacaine Hydrochloride | AL 381 | AL-381 | AL381 | Naropeine | LEA 103 | LEA-103 | LEA103 | Ropivacaine Monohydrochloride, (S)-isomer |
|
| Chemical Information |
| Molecular Formula |
C17H26N2O |
| CAS Registry Number |
84057-95-4 |
| SMILES |
CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
